RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
CUSATO J
Collezione ASL Città di Torino
Items : 99
Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. in Brain : a journal of neurology / Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.
2024
ASL Città di Torino
Gulminetti R; Ripamonti D; Antinori A; Muscatello A; Gabrieli A; Bruzzesi E; Rusconi S; Marchetti G; Bernasconi D; Trunfio M; Cinque P; Cusato J; Antonucci M; Calcagno A; Nozza S;
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
AOU Città della Salute di Torino
ASL Città di Torino
Calcagno A; D'Avolio A; Di Perri G; Trunfio M; Marinaro L; Bonora S; Avataneo V; Mula J; Antonucci M; Cusato J; Manca A; Palermiti A;
Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Stroffolini G; Lupia T; De Nicolò A; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Boglione L; Cusato J;
Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116686. doi: 10.1016/j.biopha.2024.116686. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano
Antonucci M; Nicolò A; Luxardo N; Imperiale D; Vischia F; De Cori D; Cusato J; D'Avolio A; Palermiti A; Billi M; Valz C; Chiara F; Mula J; Manca A;
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease. in Biomedicines / Biomedicines. 2024 Jan 30;12(2):320. doi: 10.3390/biomedicines12020320.
2024
AOU Città della Salute di Torino
ASL Città di Torino
Ribaldone DG; Armandi A; Saracco GM; D'Avolio A; Caviglia GP; Vernero M; Manca A; Palermiti A; Antonucci M; Cafasso C; Cusato J;
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. in Biomedicines / Biomedicines. 2024 Apr 9;12(4):824. doi: 10.3390/biomedicines12040824.
2024
ASL Città di Torino
Bertani L; Falzone MH; Manca A; D'Avolio A; Costa F; Bottari A; Fornaroli G; Caviglia GP; Saracco GM; Ceccarelli L; Palermiti A; Cusato J; Antonucci M; Ribaldone DG;
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
D'Avolio A; Di Perri G; Lupo C; Rainoldi A; Bonora S; Cuomo S; Trevisan G; Maddalone MG; Tettoni MC; Mula J; Bianco G; Chiara F; Accardo G; Palermiti A; Manca A; Antonucci M; Ferrara M; Cusato J; Mulasso A;
Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Sep;165:115103. doi: 10.1016/j.biopha.2023.115103. Epub 2023 Jul 4.
2023
ASL Città di Torino
D'Avolio A; Nicolò A; Vivo ED; Cusato J; Maiese D; Antonucci M; Venturello S; Emanuelli G; Cori D; Vischia F; Mula J; Palermiti A; Manca A;
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; Bonora S; Di Perri G; Maiese D; Ferrara M; Antonucci M; Chiara F; De Vivo ED; Costanzo M; Cusato J; Manca A; Mula J; Palermiti A;
COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; De Rosa FG; Di Perri G; Ferrara M; De Vivo ED; Ianniello A; Chiara F; Corcione S; Antonucci M; Trunfio M; Costanzo M; Palermiti A; Mula J; Cusato J; Manca A;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino
Mula J; Bonora S; D'Avolio A; Calcagno A; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Cusato J; Avataneo V; Antonucci M;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants in Diagnostics
2023
ASL Città di Torino
Palermiti A; Manca A; Di Perri G; Mula J; Bonora S; D’Avolio A; Calcagno A; Cusato J; Avataneo V; Antonucci M; Trunfio M; Marinaro L;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
Calcagno A; Rosa FG; Di Perri G; Chiara F; Antonucci M; De Nicolò A; Allegra S; De Francia S; Palermiti A; Mula J; Manca A; Cusato J; D'Avolio A;
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino
Smedile A; D'Avolio A; Cantù M; Di Perri G; Saracco GM; Cariti G; Manca A; Mula J; Antonucci M; Ciancio A; Palermiti A; Avataneo V; Troshina G; Caviglia GP; Mornese Pinna S; De Nicolò A; Boglione L; Cusato J;
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.
2022
ASL Città di Torino
Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;
Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy. in Environmental research / Environ Res. 2022 Jan;203:111901. doi: 10.1016/j.envres.2021.111901. Epub 2021 Aug 19.
2022
ARPA Piemonte
ASL Città di Torino
ASL Torino 4
Di Perri G; Cusato J; Civra A; Polato D; Brizio E; Quaglino P; Lembo D; Robotto A;
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic Study. in Molecules (Basel, Switzerland) / Molecules. 2022 Feb 3;27(3):1042. doi: 10.3390/molecules27031042.
2022
ASL Città di Torino
Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;
A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients. in Irish journal of medical science / Ir J Med Sci. 2022 Feb 19:1-8. doi: 10.1007/s11845-022-02952-9.
2022
ASL Città di Torino
Sanson G; De Nicolò A; Zerbato V; Segat L; Koncan R; Di Bella S; Cusato J; di Masi A; Palermo A; Caironi P; D'Agaro P; Luzzati R; D'Avolio A;
Obstetric and neonatal outcomes after SARS-CoV-2 infection in the first trimester of pregnancy: A prospective comparative study. in The journal of obstetrics and gynaecology research / J Obstet Gynaecol Res. 2022 Feb;48(2):393-401. doi: 10.1111/jog.15105. Epub 2021 Nov 23.
2022
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Mengozzi G; Ghisetti V; Mazzone R; Bevilacqua F; Bovetti M; Bertero L; Borella F; Cusato J; Carosso AR; Cosma S;
A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; De Cori D; Cusato J; Vischia F; Imperiale D; De Filippis G; De Nicolò A; Zeaiter S; Palermiti A; Maiese D; Mula J; Chiara F; Manca A;
Pregnancy and COVID-19: The Possible Contribution of Vitamin D. in Nutrients / Nutrients. 2022 Aug 10;14(16):3275. doi: 10.3390/nu14163275.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Cusato J; De Rosa FG; Benedetto C; D'Avolio A; Antonucci M; Corcione S; Borella F; Carosso AR; Ianniello A; De Vivo ED; Costanzo M; Manca A; Palermiti A; Cosma S;
The importance of Therapeutic Drug Monitoring during pregnancy in a HIV-positive woman taking lifelong antiretroviral therapy in Biochimica Clinica
2022
ASL Città di Torino
Cusato J; D'Avolio A; Di Perri G; Bonora S; Calcagno A; Antonucci M; Marinaro L;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants in Pharmaceuticals
2022
ASL Città di Torino
Mula J; Antonucci M; De Nicolò A; Allegra S; De Francia S; Chiara F; Di Perri G; De Rosa FG; Calcagno A; Cusato J; Palermiti A; Manca A; D’avolio A;
Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino
Di Perri G; De Nicolò A; D'Avolio A; Calcagno A; Ianniello A; De Vivo ED; Avataneo V; Cusato J; Mula J; Antonucci M; Manca A; Palermiti A;
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. in Nutrients / Nutrients. 2021 Oct 12;13(10):3571. doi: 10.3390/nu13103571.
2021
ASL Città di Torino
Calcagno A; Tempestilli M; Cusato J; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;
Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Nov 27;14(12):1230. doi: 10.3390/ph14121230.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Ribaldone DG; D'Avolio A; Astegiano M; Zanzi F; Cusato J; Ceccarelli L; Costa F; Mangia M; Mula J; Massano A; Dibitetto S; Tomasello C; Caviglia GP; Antonucci M; Bertani L;
Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.
2021
ASL Città di Torino
Barco S; Cafaro A; Palermiti A; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
Ianniello A; Manca A; De Nicolò A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino
Di Perri G; Calcagno A; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;
Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano
ASL Città di Torino
Leoni V; Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C;
The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy. in Journal of medical virology / J Med Virol. 2021 Jan;93(1):537-540. doi: 10.1002/jmv.26267. Epub 2020 Aug 13.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Katsaros D; Benedetto C; Mengozzi G; Preti M; Corcione S; Cusato J; Sciarrone A; Carosso A; Borella F; Cosma S;
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):89-102. doi: 10.1007/s40262-020-00913-y.
2021
ASL Città di Torino
van Deun L; Swen JJ; Ettaieb MHT; Yin A; Kerkhofs TMA; van der Straaten RJHM; Corssmit EPM; Gelderblom H; Kerstens MN; Feelders RA; Eekhoff M; Timmers HJLM; D'Avolio A; Cusato J; Guchelaar HJ; Haak HR; Moes DJAR;
Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 Feb 26;11(3):398. doi: 10.3390/diagnostics11030398.
2021
ASL Città di Torino
Benedetto C; Di Perri G; Filippini C; Ghisetti V; Rolfo A; Revelli A; Marozio L; Sciarrone A; Gervasoni F; Bevilacqua F; Carosso M; Cusato J; Bovetti M; Borella F; Carosso AR; Cosma S;
COVID-19: unanswered questions and work for a better knowledge. in Minerva medica / Minerva Med. 2021 Feb;112(1):111-113. doi: 10.23736/S0026-4806.20.07153-0. Epub 2020 Nov 18.
2021
ASL Città di Torino
Cusato J;
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino
Scabini S; Montrucchio G; De Nicolò A; Corcione S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. in American journal of obstetrics and gynecology / Am J Obstet Gynecol. 2021 Apr;224(4):391.e1-391.e7. doi: 10.1016/j.ajog.2020.10.005. Epub 2020 Oct 8
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cosma S; Carosso AR; Cusato J;
Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery. in Journal of reproductive immunology / J Reprod Immunol. 2021 Apr;144:103285. doi: 10.1016/j.jri.2021.103285. Epub 2021 Feb 2.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Benedetto C; Preti M; Ghisetti V; Borella F; Antonucci M; Marozio L; Revelli A; Corcione S; Cusato J; Carosso AR; Cosma S;
Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study in Pharmaceuticals
2021
ASL Città di Torino
D’avolio A; Ribaldone DG; Astegiano M; Zanzi F; Costa F; Ceccarelli L; Mula J; Mangia M; Dibitetto S; Massano A; Caviglia GP; Tomasello C; Antonucci M; Bertani L; Cusato J;
VITAMIN D-RELATED GENETICS AS PREDICTOR OF RESPONSE TO ADALIMUMAB IN CROHN’S DISEASE in Digestive and Liver Disease
2021
ASL Città di Torino
D’avolio A; Astegiano M; Ribaldone DG; Zanzi F; Costa F; Ceccarelli L; Mula J; Mangia M; Massano A; Dibitetto S; Caviglia GP; Tomasello C; Antonucci M; Bertani L; Cusato J;
Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters. in PloS one / PLoS One. 2021 Aug 5;16(8):e0254875. doi: 10.1371/journal.pone.0254875. eCollection 2021.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Ghisetti V; Di Perri G; Preti M; Stura I; Gervasoni F; Carosso AR; Cusato J; Borella F; Carosso M; Cosma S;
Prenatal biochemical and ultrasound markers in covid-19 pregnant patients: A prospective case-control study in Diagnostics
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Ghisetti V; Filippini C; Rolfo A; Revelli A; Marozio L; Sciarrone A; Gervasoni F; Carosso M; Bevilacqua F; Bovetti M; Cusato J; Borella F; Carosso AR; Cosma S;
Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers in Diagnostics
2021
ASL Città di Torino
Nigra M; Atzori C; Imperiale D; Bonora S; Di Perri G; Calcagno A; Caligaris G; Trunfio M; Ghisetti V; Cusato J;
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring. in Frontiers in pharmacology / Front Pharmacol. 2022 Jan 5;12:755184. doi: 10.3389/fphar.2021.755184. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Veglio F; D'Avolio A; De Rosa FG; Cusato J; Pappaccogli M; Palermiti A; Rabbia F; Fanelli E; De Nicolò A; Avataneo V;
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. in Nutrients / Nutrients. 2020 May 9;12(5):1359. doi: 10.3390/nu12051359.
2020
ASL Città di Torino
Avataneo V; D'Avolio A; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M;
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study. in The Journal of infectious diseases / J Infect Dis. 2020 Jun 29;222(2):263-272. doi: 10.1093/infdis/jiaa088.
2020
ASL Città di Torino
Castelnuovo B; Di Perri G; Lamorde M; Calcagno A; Cusato J; Kafufu B; Borderi M; Mwaka E; Kasozi W; Scabini S; Kaimal A; Costa C;
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
D'Avolio A; Antonucci M; Manca A; Avataneo V; Allegra S; De Francia S; De Nicolò A; Cusato J;
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152.
2020
ASL Città di Torino
de Nicolò A; Avataneo V; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;
Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Barco A; Nunnari G; Imperiale D; Cusato J; Tettoni M; Trentalange A; Prochet A;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
Ferrara M; Ianniello A; De Nicolò A; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino
Calcagno A; Cusato J; Marinaro L; Avataneo V; Di Perri G; Bonora S;
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer in Biochimica Clinica
2020
ASL Città di Torino
D’Avolio A; Grossi F; Ferlazzo G; Boccardo S; Coco S; Dal Bello MG; Di Perri G; Leggieri A; Cossu I; Rijavec E; Mingari MC; Pietra G; Ottonello S; Carrega P; Genova C; Tomasello C; Cusato J;
RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS in Digestive and Liver Disease
2020
ASL Città di Torino
D'Avolio A; Saracco GM; Astegiano M; Mangia M; Cusato J; Ribaldone DG;
Pharmacogenetic markers able to predict lipid-related parameters in a cohort of ritonavir treated patients in Biochimica Clinica
2020
ASL Città di Torino
Palermiti A; Marinaro L; Avataneo V; De Nicolò A; D'Avolio A; Bonora S; Di Perri G; Cusato J; Calcagno A; Antonucci M;
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
AOU San Luigi di Orbassano
ASL Città di Torino
Piga A; Avataneo V; De Nicolò A; Massano D; Pirro E; Longo F; Cusato J; De Francia S; D'Avolio A; Allegra S;
LC-MS application for therapeutic drug monitoring in alternative matrices. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29.
2019
ASL Città di Torino
Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab. in Cancers / Cancers (Basel). 2019 Jan 21;11(1):125. doi: 10.3390/cancers11010125.
2019
ASL Città di Torino
Grossi F; Ferlazzo G; Boccardo S; Coco S; Di Perri G; Dal Bello MG; Leggieri A; Rijavec E; Cossu I; Mingari MC; Ottonello S; Pietra G; Carrega P; Genova C; Tomasello C; D'Avolio A; Cusato J;
Influence of Vitamin D in advanced non-small cell lung cancer patients treated with nivolumab in Cancers
2019
ASL Città di Torino
D’Avolio A; Grossi F; Ferlazzo G; Boccardo S; Coco S; Dal Bello MG; Di Perri G; Leggieri A; Rijavec E; Cossu I; Mingari MC; Pietra G; Ottonello S; Carrega P; Tomasello C; Genova C; Cusato J;
A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance. in Therapeutic drug monitoring / Ther Drug Monit. 2018 Oct;40(5):602-609. doi: 10.1097/FTD.0000000000000536.
2018
ASL Città di Torino
D?Avolio A; Danesi R; Corcione S; Arrigoni E; Di Paolo A; Cusato J; Fatiguso G; Allegra S;
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F;
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
AOU San Luigi di Orbassano
ASL Città di Torino
Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A;
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenetic of voriconazole antifungal agent in pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2018 Jul 1;19(11):913-925. doi: 10.2217/pgs-2017-0173. Epub 2018 Jun 19.
2018
ASL Città di Torino
D'Avolio A; Perri GD; Avataneo V; Nicolò A; Cusato J; Francia S; Pirro E; Carcieri C; Allegra S; Fatiguso G;
Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
D'Avolio A; Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; Carcieri C;
Precision medicine for HIV: where are we? in Pharmacogenomics / Pharmacogenomics. 2018 Jan;19(2):145-165. doi: 10.2217/pgs-2017-0123. Epub 2017 Dec 5.
2018
ASL Città di Torino
D'Avolio A; Calcagno A; Nicolò A; Allegra S; Cusato J;
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
Cusato J; Carcieri C; De Nicolò A; Di Perri G; D'Avolio A; Allegra S; Fatiguso G; Pirro E; Favata F; De Francia S;
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Jan;28(1):17-22. doi: 10.1097/FPC.0000000000000315.
2018
ASL Città di Torino
Allegra S; Cusato J; De Francia S; Longo F; Pirro E; Massano D; Piga A; D'Avolio A;
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia. in Journal of neurovirology / J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Di Perri G; Imperiale D; Sala A; Ferrara M; Pesci Kincer L; Audagnotto S; Cusato J; Martini C; Romito A; Ghisetti V; Joseph SB; Trunfio M; Calcagno A;
Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
AOU San Luigi di Orbassano
ASL Città di Torino
D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino
Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Vitamin D plasma level is able to affect nivolumab drug exposure in a cohort of patients with non small cell lung cancer in Biochimica Clinica
2018
ASL Città di Torino
D'Avolio A; Di Perri G; Grossi F; Ferlazzo G; Mingari MC; Cossu I; Pietra G; Ottonello S; Tomasello C; Genova C; Carrega P; Cusato J;
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients in Pharmacogenetics and Genomics
2018
ASL Città di Torino
D'Avolio A; Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S;
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. in Antiviral therapy / Antivir Ther. 2018;23(4):373-377. doi: 10.3851/IMP3207.
2018
ASL Città di Torino
De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino
El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Sep;53:195-198. doi: 10.1016/j.meegid.2017.05.026. Epub 2017 Jun 1.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino
Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;
Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. in European journal of public health / Eur J Public Health. 2017 Oct 1;27(5):938-941. doi: 10.1093/eurpub/ckx025.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino
Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; De Nicolò A; Di Perri G; Cusato J; Pirro E; Carcieri C; Favata F; De Francia S; Fatiguso G; Allegra S;
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
D'Avolio A; Cusato J; Di Perri G; De Nicolò A; De Francia S; Carcieri C; Pirro E; Favata F; Fatiguso G; Allegra S;
Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino
Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino
Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino
Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V;
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino
Calcagno A; Cusato J; D'Avolio A; Bonora S;
UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino
Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A;
Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino
Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A;